Estrogen agonists/antagonists are compounds with tissue-selective actions. The pharmacological goal of these compounds is to produce beneficial estrogenic actions in certain tissues (e.g., bone ...

Last year was the first full year that Mounjaro was commercially available. Sales of the diabetes treatment topped $5 billion ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes and obesity. They are in a class of drugs known as incretin mimetics. GLP-1 drugs are more commonly known by ...

Research is highlighting how GLP-1 is expressed in prostate cancer, suggesting that GLP-1 agonists might have a future role in the management of this cancer.

It’s hard to turn on the TV or read any publication these days without seeing ads for or references to the increasing number of GLP-1 Agonists that have been approved for or are being used for ...

The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of ...

As per a survey conducted by GlobalData, a good implementation in obesity clinical trial design could use methods such as ...

New data find gastric contents after fasting aren't higher than nondiabetics, but an expert endocrinologist disputes that ...

Three years ago injecting yourself skinny seemed positively futuristic. Now, everyone from Oprah Winfrey and Elon Musk to ...

Novo Nordisk is under intense pressure both from competitors and now from regulators at the FTC. Read more to see our analysis on NVO stock.

Preclinical results of EL-22 from a 2022 study demonstrated physiological (serum creatine kinase level), physical (body weight change), and ...